Effects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia Patients

Clinical trial NCT03784222 · TERMINATED

Trial details

NCT number: NCT03784222
Sponsor: Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

First Episode Schizophrenia Social Function Cognition Function Blonanserin

Start date: 2019-01-22
Primary completion: 2022-11-22
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.